Notably, using the same breast cancer TMA as in this study, GRN expression was found to correlate with the same clinicopathological features as CD163+ macrophages in TS [15] as well as with the density of CD163+ macrophages in TS. This evidence concerns the gene GRN and breast carcinoma.